Uncategorized

A Faculty Member from the Plant Biotechnology Department Participates in a Discussion Seminar

A Faculty Member from the Plant Biotechnology Department Participates in a Discussion Seminar Assistant Lecturer Doha Maysar Majeed from the Plant Biotechnology Department at the Biotechnology Research Center, Al-Nahrain University, participated in a discussion seminar titled: “Internal Review and Ensuring the Sustainability of Institutional Accreditation Standards Application,” organized by the Center of Excellence for Innovation and Development at the American University of Baghdad. Her participation involved attending the conference in person, which aimed to encourage internal review by external evaluators to maintain continuous accreditation. The conference was organized by Dr. Khalil Ibrahim Mahmoud and covered key topics related to quality and accreditation, including: The importance of internal review in educational institutions The role of reviewers before field visits Sustaining the application of standards after obtaining conditional or full accreditation The stages of the review process and how to develop a detailed review plan

Loading

A Faculty Member from the Plant Biotechnology Department Participates in a Discussion Seminar Read More »

New Patent for Pancreatic Cancer Treatment Using APR-246

New Patent for Pancreatic Cancer Treatment Using APR-246 Dr. Ali Haider Mohammed Ali Al-Hamar, a researcher from the Biotechnology Research Center at Al-Nahrain University, has obtained a patent titled: “The Use of APR-246 as a Synergistic Treatment with 5-Fluorouracil to Induce Apoptosis in Pancreatic Cancer Cells.” This patent holds significant importance in the field of pancreatic cancer treatment, as this type of cancer is among the most lethal due to its resistance to conventional therapies. The drug APR-246 targets the p53 protein, which is mutated in approximately 75% of pancreatic cancer cases, making it a promising target for enhancing treatment efficacy. Preclinical study results showed that APR-246, when used alone, was effective against both wild-type and mutated pancreatic cancer cells. However, the most remarkable finding was the synergistic effect observed when it was combined with 5-fluorouracil, leading to a boost in treatment effectiveness and induction of cancer cell apoptosis by up to 80%. This breakthrough opens new avenues for reducing chemotherapy doses and minimizing side effects, thereby improving treatment efficacy and patient safety. This study was the result of a collaborative effort between the researcher from the Biotechnology Research Center and other researchers from the College of Pharmacy at Al-Mustansiriyah University. Moreover, the same research has been published in a prestigious scientific journal specializing in new cancer treatment research, classified within the Q1 category in Scopus and Clarivate rankings. These findings lay a strong foundation for future preclinical and clinical trials, especially since APR-246 has previously shown success in treating other types of cancer with low side effects. For more information about the researcher’s biography, visit: Researcher’s Profile https://cv.nahrainuniv.edu.iq/en/view/2153 Research Link: Springer Article https://link.springer.com/article/10.1007/s10637-023-01380-5

Loading

New Patent for Pancreatic Cancer Treatment Using APR-246 Read More »

A Faculty Member from the Center Participates in the International Conference of the College of Pharmacy

A Faculty Member from the Center Participates in the International Conference of the College of Pharmacy Professor Dr. Zainab Yassin Mohammed, a faculty member in the Department of Plant Biotechnology at the Center for Biotechnology Research, Al-Nahrain University, participated in the 6th International Conference of the College of Pharmacy at Al-Mustansiriyah University, in collaboration with the College of Pharmacy at the American University. Her participation included presenting a research study titled: “The Effect of Resveratrol Extracted from Iraqi Black Grape Peels on Blood Sugar Levels in Laboratory Animals.” The study aimed to purify a therapeutic compound, resveratrol, from black grape peel waste and examine its effects on blood sugar levels and liver function in laboratory animals. The results showed that resveratrol significantly reduced blood sugar levels in diabetic-induced laboratory animals and restored liver function to normal levels, compared to conventional medications. The study was conducted by Prof. Dr. Zainab Yassin, Prof. Dr. Hazem Ismail, and Dr. Jasim Abdullah. In recognition of the significance of her research and its impact on public health, Dr. Zainab Yassin was honored with a Certificate of Participation.

Loading

A Faculty Member from the Center Participates in the International Conference of the College of Pharmacy Read More »

Science Students at the Biotechnology Research Center

Science Students at the Biotechnology Research Center The Biotechnology Research Center at Al-Nahrain University welcomed a visiting delegation from the Department of Life Sciences, College of Science, University of Baghdad. The visit focused on the Department of Medical and Molecular Biotechnology, aiming to introduce students to the latest advancements in biotechnology, strengthen the relationship between the university and the center, and provide students with opportunities to explore practical applications of life sciences in biotechnology. The staff of the Medical Biotechnology Department delivered presentations on various techniques, including PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), electrophoresis, and cancer cell culturing

Loading

Science Students at the Biotechnology Research Center Read More »